Amifostine

Ethyol - PWS IV 500MG/Vial

500 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

EthyolBrazil · Merck Sharp & Dohme Farmaceutica Ltda.Same brand
EthyolBrazil · Schering-Plough Produtos Farmacêuticos LtdaSame brand
EthyolBrazil · Mantecorp Indústria Química e Farmacêutica S.A.Same brand
ETHYOL 50 mg/ml POLVO PARA SOLUCION PARA PERFUSIONSpain · 500 mg · polvo para solución para perfusión · Clinigen Healthcare B.V.Same brand
EthyolUnited States · 375MG/VIAL, 500MG/VIAL · injectable · Legacy PharmaSame brand
AmifostineUnited States · 500MG/VIAL · injectable · Sun PharmSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Amifostine

Ethyol - PWS IV 500MG/Vial

500 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1996

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Amifostine
Strength: 500 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1996
Registration: DIN 02218054
Marketing authorisation holder: Medimmune Oncology, INC.
ATC code: V03AF05
Group: Various
Supply: PRESCRIPTION